Skip to main content
logo
Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.7375
-0.0155 (-2.06%)
At close: Aug 10, 2026, 4:00 PM EDT
0.7105
-0.0270 (-3.66%)
After-hours: Aug 10, 2026, 5:03 PM EDT

Citius Oncology Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Dec '22 Dec '21
Market Cap
6917099---
Market Cap Growth
-54.19%70.46%----
Enterprise Value
69.74169.41103.26000
Last Close Price
0.742.031.39---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Dec '22 Dec '21
Forward PE
-89.00----
PB Ratio
1.993.782.16---
P/TBV Ratio
1.763.322.05---
P/FCF Ratio
--787.14---
P/OCF Ratio
--787.14---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Dec '22 Dec '21
EV/FCF Ratio
--817.22---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Dec '22 Dec '21
Debt / Equity Ratio
0.110.080.0800-
Debt / FCF Ratio
--30.08---
Net Debt / Equity Ratio
0.030.000.08--0.84-
Net Debt / EBITDA Ratio
-0.030.01-0.18-2.09-
Net Debt / FCF Ratio
-0.070.0230.07-6.03-
Asset Turnover
0.050000-
Inventory Turnover
0.0500---
Quick Ratio
0.060.080.0009.08-
Current Ratio
0.500.560.340.3711.85-
Return on Equity (ROE)
-90.75%-54.42%-59.01%-98.12%220.43%-
Return on Assets (ROA)
-41.87%-26.52%-32.02%-21.91%-0.41%-
Return on Invested Capital (ROIC)
-96.56%-51.90%-56.04%-99.23%-245.18%-
Return on Capital Employed (ROCE)
-81.24%-45.62%-52.51%-25.56%-0.41%-

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Dec '22 Dec '21
FCF Yield
--0.13%---
Buyback Yield / Dilution
-20.32%-7.66%-2798.38%-25.87%-8.14%-
Total Shareholder Return
-20.32%-7.66%-2798.38%-25.87%-8.14%-
SEC Filings: 10-K · 10-Q